Cancel
Nearby: Atlanta, GA 30308

Access Your Account

New to Healthgrades?

Join for free!

Or, sign in directly with Healthgrades:

Doctors and their Administrators:
Sign Up or Log In

Treating Psoriasis With Injections

By

Aaron Mangold, MD

Was this helpful? (18)
This content is selected and managed by the Healthgrades editorial staff and is brought to you by an advertising sponsor.
x

This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the HealthGrades advertising policy.

ADVERTISEMENT
Injection

Treatment for psoriasis and many other inflammatory diseases was revolutionized with the introduction of biologics. But to understand how groundbreaking these types of drugs are for psoriasis, it’s important to look at how the condition was treated in the past.


Before Biologics

Psoriasis is a chronic, inflammatory skin condition characterized by red, scaly plaques that typically show up on the knees, elbows and scalp. Psoriasis is characterized by over activity of certain parts of the immune system. Before biologics, patients were often treated using non-specific immunosuppressants that would knock out many parts of the immune system. Drugs most commonly used were cyclosporine and methotrexate, as well as drugs that are toxic to the blood cells like hydroxyurea. It’s almost like using a cannon when all that was needed was a sling shot.

Biologic medications have shown great success in helping psoriasis patients clear their skin. However, sometimes it’s necessary to switch to a new biologic—and that’s okay.

2016 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

But then some researchers started thinking, “What’s really going on with psoriasis? What specific immune processes are faulty?” Think of it this way: the inflammatory pathways involved in psoriasis are like a stream of molecules heading to and from the skin’s surface. In a person without psoriasis, these pathways activate the immune system when there’s a cut or scrape, sending cells to the skin’s surface to fight infection and heal wounds. If you have psoriasis, your immune response is overactive and may jump into action for no apparent reason.

TNF-Alpha Inhibitors

As we began to understand more of which biological processes were really driving psoriasis and psoriatic lesions, drug companies started making medications that targeted specific pathways involved in the disease. Enter Enbrel (etanercept), the first drug approved by the Federal Drug Administration (FDA) in 2004 to treat psoriasis. Enbrel, along with drugs like Humira (adalimumab) and Remicade (infliximab), is classified as a tumor necrosis factor-alpha (TNF-alpha) blockers. TNF-alpha blockers are either self-injectable at home, or intravenous infusions administered by a doctor. Injection frequency varies from once or twice a week to every 6-8 weeks.

TNF-alpha is a cytokine, or protein, within your body that prompts the creation of inflammation. If you have psoriasis, you likely have excess production of TNF-alpha in the skin and possibly the joints, so by blocking this specific pathway, the goal is to slow or stop the inflammatory process in psoriasis -- and it works really well. In fact, we saw a dramatically higher rate of people responding to treatment--with up to 75% improvement, and very few side effects.

Specific Interleukin Blocking

Interleukins are naturally occurring proteins that regulate many aspects of the inflammation and immune response. The second class of biologics to come to market specifically target interleukin 12 and 23 (IL-12 and IL-23); of those, Stelara (ustekinumab) is the most well-known. The major difference between IL-12/23 blockers and TNF-alpha blockers is that the former works on two pathways known to be associated with inflammatory psoriasis; the latter, only one. Another major benefit of the IL-12/23 blockers, is that you only have to have it injected quarterly (every three months), rather than the more frequent dosing required of TNF-alpha inhibitor.

A newer class of injectable biologics, IL-17 blockers, is even more promising. IL-17 is another protein involved in immune responses. These new IL-17 blockers target block downstream in the most critical pathway in psoriasis and work faster than older injectable.  Patients typically see vast improvement within two to four weeks. In comparison, some of the TNF-alpha blockers reach maximum efficacy at 12 to 16 weeks. Cosentyx (secukinumab) is the first approved IL-17 blocker. After taking weekly doses for the first four weeks on the medication, patients only have to inject on a monthly basis.  Taltz (Ixekizumab) was recently FDA approved and is taken every 2 weeks for a period of time and then monthly.



THIS CONTENT DOES NOT PROVIDE MEDICAL ADVICE. This content is provided for informational purposes and reflects the opinions of the author. It is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified healthcare professional regarding your health. If you think you may have a medical emergency, contact your doctor immediately or call 911.


Aaron Mangold, MD

Aaron Mangold, MD, is an assistant professor of dermatology at the Mayo Clinic in Arizona.
View his Healthgrades profile >

Was this helpful? (18)

© 2016 Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced or reprinted without permission from Healthgrades Operating Company, Inc. Use of this information is governed by the Healthgrades User Agreement.

Your opinion matters!



Please fill out this short, 1-3 minute survey about Treating Your Psoriasis Effectively. Your answers are anonymous and will not be linked to you personally.

The survey will appear at the end of your visit.

Thank you!

A survey will be presented to you after you finish viewing our Treating Your Psoriasis Effectively content.

You Might Also Like

How Psoriasis Affects Men and Women Differently

When it comes to different triggers and treatments, men and women experience psoriasis differently.

What to Expect From Your Psoriasis Medication

Even though psoriasis treatment doesn't offer a cure, what can you expect the medication to do?

Share via Email

PREVIOUS ARTICLE:

The Stress and Psoriasis Connection

NEXT ARTICLE:

Frequently Asked Questions About Moderate To Severe Psoriasis

Up Next

Frequently Asked Questions About Moderate To Severe Psoriasis